Machine learning model predicts CDK4/6 inhibitor effectiveness in metastatic breast cancer
A machine learning (ML) model incorporating both clinical and genomic factors outperformed models based solely on either clinical or genomic data in predicting which patients with hormone receptor (HR)-positive, HER2-negative…
Read More...
Read More...